# Processed Orange and the Glycemic Response

> **NCT02112851** · NA · COMPLETED · sponsor: **PepsiCo Global R&D** · enrollment: 38 (actual)

## Conditions studied

- Maximum Observed Plasma Glucose Concentration (Cmax)

## Interventions

- **OTHER:** Orange flavored beverage

## Key facts

- **NCT ID:** NCT02112851
- **Lead sponsor:** PepsiCo Global R&D
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-07
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2021-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02112851

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02112851, "Processed Orange and the Glycemic Response". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02112851. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*